Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.67 USD | -1.18% | -0.60% | -12.11% |
06/06 | I-Mab Appoints Phillip Dennis as Chief Medical Officer | CI |
05/06 | I-Mab Collaborates With Bristol-Myers to Evaluate Givastomig in Combination Study for Gastric, Esophageal Cancers | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.11% | 13Cr | |
+55.32% | 82TCr | |
+44.05% | 64TCr | |
-6.75% | 35TCr | |
+13.56% | 31TCr | |
+10.68% | 30TCr | |
+16.57% | 24TCr | |
+13.31% | 22TCr | |
+8.48% | 17TCr | |
-2.81% | 16TCr |
- Stock Market
- Equities
- IMAB Stock
- News I-Mab
- HC Wainwright Adjusts I-Mab's Price Target to $45 From $70, Maintains Buy Rating